An Observational Study to Understand The Use and Effect of Voglibose in Indian Patients Suffering from Type 2 Diabetes
- Conditions
- Health Condition 1: null- Type 2 Diabetes Mellitus
- Registration Number
- CTRI/2017/02/007878
- Lead Sponsor
- Torrent Pharmaceuticals Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 2500
1. Patients willing to provide informed consent
2. Female or male patients aged 18 years or above
3. Adult patient with inadequately controlled T2DM with a HbA1C between 7.0% and 10.0% despite using diet plus exercise and/or antidiabetic agents
4. Requirement for Voglibose as monotherapy or add-on therapy
5. Patients must provide written consent to use personal and/or health data prior to the entry into the study
1. Patients with Type 1 diabetes mellitus
2. Any medical condition of the patient which in opinion of investigator would interfere with safe completion of the study
3. History of frequent attack of hypoglycemia or loss of consciousness due to hypoglycemia
4. Has history of ketoacidosis or hyperosmotic status/coma
5. Pregnancy or lactation
6. Women of child bearing potential not ready to use an effective contraceptive method during the study
7. Patients participating in any other clinical trials
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method